SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Noncanonical Mutations Conferring Resistance to InSTIs
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
Session Overview
Daniel R. Kuritzkes
Harvard Medical School, Boston, MA, USA
Env Mutations Are a Gateway for Acquisition of InSTI Resistance (ABSTRACT
551)
Yuta Hikichi
National Cancer Institute at Frederick, Frederick, MD, USA
Nucleocapsid Mutations During Virologic Failure of an Integrase Inhibitor-Based Regimen (ABSTRACT
585)
Charlotte Charpentier
Assistance Publique – Hôpitaux de Paris, Paris, France
Noncanonical Resistance Mutations in TLD-Treated Individuals With Unexplained Virologic Failure (ABSTRACT
553)
Nicola Coetzee
Stellenbosch University, Cape Town, South Africa
Characterization of Mutations Outside the Integrase in HIV-1 Individuals in Whom Dolutegravir Failed (ABSTRACT
550)
Aurelie Minelle Kengni Ngueko
Centre International de Référence Chantal Biya, Yaoundé, Cameroon
Discussion With Audience Questions and Answers
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
